Trinity Biotech PLC (TRIB) stock
TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 1/30
$5.83−0.18 (-3.08%)
Close on Nov 18, 2026Market cap $108.99MP/E –Yield –
Trinity Biotech operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$5.93M. The highest annual figure on record is $23.76M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.93M | – |
| FY2024 | Dec 31, 2024 | -$4.19M | – |
| FY2023 | Dec 31, 2023 | -$11.56M | – |
| FY2022 | Dec 31, 2022 | -$921.00K | -107.0% |
| FY2021 | Dec 31, 2021 | $13.24M | -44.3% |
| FY2020 | Dec 31, 2020 | $23.76M | +338.5% |
| FY2019 | Dec 31, 2019 | $5.42M | -25.1% |
| FY2018 | Dec 31, 2018 | $7.23M | -21.8% |
| FY2017 | Dec 31, 2017 | $9.25M | -9.6% |
| FY2016 | Dec 31, 2016 | $10.23M | -22.3% |
| FY2015 | Dec 31, 2015 | $13.16M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2018 | Jun 30, 2018 | $1.74M | – |
| Q2 FY2017 | Jun 30, 2017 | $3.37M | – |
See a number that looks wrong?